SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 65 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.7%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GRACE BROTHERS MANAGEMENT LLC | 2,800,000 | $6,773,000 | 6.36% |
SILVERBACK ASSET MANAGEMENT LLC | 19,709,000 | $47,671,000 | 5.58% |
Sage Capital Management, LLC | 1,660,000 | $4,009,000 | 3.83% |
SYMPHONY ASSET MANAGEMENT LLC | 15,190,000 | $36,741,000 | 3.79% |
BASSO CAPITAL MANAGEMENT, L.P. | 8,187,000 | $19,782,000 | 3.03% |
CAMDEN ASSET MANAGEMENT L P /CA | 29,798,000 | $72,074,000 | 3.00% |
Wellesley Asset Management | 15,250 | $36,969,000 | 2.29% |
GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,600,000 | $20,801,000 | 2.12% |
BNP PARIBAS FINANCIAL MARKETS | 7,500,000 | $1,814,100,096,000 | 1.58% |
WOLVERINE ASSET MANAGEMENT LLC | 31,156,000 | $75,372,000 | 1.57% |